Information Provided By: 
Fly News Breaks for January 8, 2018
ATRC
Jan 8, 2018 | 14:14 EDT
Piper Jaffray analyst Matt O'Brien noted that the midpoint of AtriCure's 2018 revenue guidance is below the consensus estimate, but he believes management is being conservative, which he said they have been historically. The analyst, who remains confident in the stock's set up for 2018, would be buying shares today, he tells investors. O'Brien keeps an Overweight rating on AtriCure, which is up fractionally to $18.03 in afternoon trading.
News For ATRC From the Last 2 Days
There are no results for your query ATRC
